Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Statistics

Total Valuation

BME:BST has a market cap or net worth of EUR 24.31 million. The enterprise value is 26.14 million.

Market Cap	24.31M
Enterprise Value	26.14M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BME:BST has 69.27 million shares outstanding. The number of shares has increased by 14.28% in one year.

Current Share Class	69.27M
Shares Outstanding	69.27M
Shares Change (YoY)	+14.28%
Shares Change (QoQ)	+7.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.20
PB Ratio	3.68
P/TBV Ratio	5.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.96
EV / Sales	8.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-298.30

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.32.

Current Ratio	0.81
Quick Ratio	0.81
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-23.81
Interest Coverage	-12.62

Financial Efficiency

Return on equity (ROE) is -44.40% and return on invested capital (ROIC) is -14.77%.

Return on Equity (ROE)	-44.40%
Return on Assets (ROA)	-9.11%
Return on Invested Capital (ROIC)	-14.77%
Return on Capital Employed (ROCE)	-22.36%
Revenue Per Employee	87,210
Profits Per Employee	-85,803
Employee Count	34
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	-139,119
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.18% in the last 52 weeks. The beta is 1.66, so BME:BST's price volatility has been higher than the market average.

Beta (5Y)	1.66
52-Week Price Change	+22.18%
50-Day Moving Average	0.39
200-Day Moving Average	0.35
Relative Strength Index (RSI)	34.40
Average Volume (20 Days)	290,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:BST had revenue of EUR 2.97 million and -2.92 million in losses. Loss per share was -0.04.

Revenue	2.97M
Gross Profit	2.62M
Operating Income	-2.29M
Pretax Income	-3.06M
Net Income	-2.92M
EBITDA	-1.29M
EBIT	-2.29M
Loss Per Share	-0.04

Balance Sheet

The company has 261,856 in cash and 2.09 million in debt, giving a net cash position of -1.82 million or -0.03 per share.

Cash & Cash Equivalents	261,856
Total Debt	2.09M
Net Cash	-1.82M
Net Cash Per Share	-0.03
Equity (Book Value)	6.61M
Book Value Per Share	0.10
Working Capital	-851,300

Cash Flow

In the last 12 months, operating cash flow was -73,854 and capital expenditures -13,765, giving a free cash flow of -87,619.

Operating Cash Flow	-73,854
Capital Expenditures	-13,765
Free Cash Flow	-87,619
FCF Per Share	-0.00

Margins

Gross margin is 88.19%, with operating and profit margins of -77.17% and -98.39%.

Gross Margin	88.19%
Operating Margin	-77.17%
Pretax Margin	-103.08%
Profit Margin	-98.39%
EBITDA Margin	-43.60%
EBIT Margin	-77.17%
FCF Margin	n/a

Dividends & Yields

BME:BST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.28%
Shareholder Yield	-14.28%
Earnings Yield	-12.00%
FCF Yield	-0.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:BST has an Altman Z-Score of -8.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.07
Piotroski F-Score	3